Hepatitis B incidence and prevention with antiretroviral therapy among HIV-positive individuals in Uganda

201734 citationsJournal Articlegreen Open Access

Authors

Emmanuel Seremba · Makerere University

Victor Ssempijja · Frederick National Laboratory for Cancer Research

Sarah Kalibbala · Rakai Health Sciences Program

Ronald H. Gray · Johns Hopkins University

Maria J. Wawer · Johns Hopkins University

Fred Nalugoda · Rakai Health Sciences Program

Corey Casper

Abstract

HBV continues to be acquired in adulthood among HIV-positive Ugandans and HBV incidence is dramatically reduced with HBV-active ART. In addition to widespread vaccination, initiation of ART may prevent HBV acquisition among HIV-positive adults in sub-Saharan Africa.

Topics & Keywords

Hepatitis B Virus Studies Hepatitis C virus research HIV/AIDS Research and Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: AIDS

Volume 31, Issue 6, pp. 781-786

DOI: 10.1097/qad.0000000000001399

Field-Weighted Citation Impact: 2.24